Vancomycin injection - Viatris
Alternative Names: Vancomycin hydrochloride for injection - ViatrisLatest Information Update: 02 Dec 2021
At a glance
- Originator Mylan
- Developer Viatris Inc
- Class Antibacterials; Glycopeptides; Peptide antibiotics
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered Bacterial endocarditis; Bone and joint infections; Respiratory tract infections; Sepsis; Skin and soft tissue infections
Most Recent Events
- 10 Jul 2018 Registered for Bacterial endocarditis (In neonates, In infants, In children, In adults, In the elderly, In adolescents) in USA (IV)
- 10 Jul 2018 Registered for Bone and joint infections (In neonates, In infants, In children, In adolescents, In adults, In the elderly) in USA (IV)
- 10 Jul 2018 Registered for Respiratory tract infections (In neonates, In infants, In children, In adolescents, In adults, In the elderly) in USA (IV)